NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2026
Back to search
Official data from USPTO
MUCOVIRAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
05/15/2026
Trademark type
Word
Nice classes
5
Filing date
10/04/2013
Registration date
04/08/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/26/2021
Last transaction
05/15/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
MARTIN, JENNIFER MCGARRY
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
A. NATTERMANN & Cie GMBH
Sanofi-Aventis Deutschland GmbH
Boehringer Ingelheim International GmbH
Representatives
Boehringer Ingelheim GmbH, Corporate Legal Intellectual Property
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the respiratory system
Publications
History of USPTO decisions and trademark events.
27 publications found
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/03/2023
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/17/2022
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/11/2022
INPC
INVALIDATION PROCESSED
03/10/2022
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/26/2021
C71T
CANCELLED SECTION 71
02/26/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
08/13/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/02/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/05/2018
DCPN
CHANGE OF OWNER RECEIVED FROM IB
11/13/2017
GPNX
NOTIFICATION PROCESSED BY IB
05/29/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/13/2014
FIMP
FINAL DISPOSITION PROCESSED
05/13/2014
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
05/08/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
04/08/2014
PUBO
PUBLISHED FOR OPPOSITION
01/21/2014
GPNX
NOTIFICATION PROCESSED BY IB
01/16/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/01/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/01/2014
NPUB
NOTICE OF PUBLICATION
01/01/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2013
DOCK
ASSIGNED TO EXAMINER
12/10/2013
MAFR
APPLICATION FILING RECEIPT MAILED
11/12/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2013
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/04/2013
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
11/01/2013
Continuous trademark protection
Get notified about every new filing that threatens MUCOVIRAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.